| Saskatchewan Drug Information Services (SDIS) |
In order to provide greater information to health care practitioners and the general public, Canada’s Research Based Pharmaceutical Companies (Rx&D) and the Canadian Generic Pharmaceutical Association (CGPA) began collecting information on behalf of their individual member companies on current and impending drug shortages in the fall of 2011. Rx&D has now turned over its database architecture (i.e. the former Rx&D Drug Shortages Database) and opened its use to non-Rx&D members (i.e. all market authorization holders) who are authorized to sell medicines in Canada, and who may need to use the site to report a drug shortage. Iinformation is being provided on a voluntary basis. It does not necessarily include all pharmaceutical companies in Canada, and therefore there may be gaps in the data.
Saskatchewan Drug information Service (SDIS) is not responsible for the content of this database, and does not assume any liability that may arise from any use of or reliance on the information contained therein. The information in the database been provided by drug manufacturers, and is presented here for reference purposes only. There is no warranty, representation or guarantee with respect to the accuracy, timeliness or completeness of this information. SDIS accepts no responsibility for any errors or omissions, and expressly disclaims any such responsibility.
SDIS cannot accept phone, email, fax, or other inquiries about the content of this information. Inquiries regarding specific drug shortages should be directed to the appropriate drug manufacturer as identified. Questions about alternatives for shorted drugs and drug plan coverage for alternatives may be directed to the appropriate provincial drug information service.